Detalhe da pesquisa
1.
Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study.
EClinicalMedicine
; 59: 101946, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-37223439
2.
A pragmatic approach for engineering porous mannitol and mechanistic evaluation of particle performance.
Eur J Pharm Biopharm
; 94: 1-10, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25960332